全文获取类型
收费全文 | 31609篇 |
免费 | 1961篇 |
国内免费 | 144篇 |
专业分类
耳鼻咽喉 | 364篇 |
儿科学 | 864篇 |
妇产科学 | 586篇 |
基础医学 | 3544篇 |
口腔科学 | 704篇 |
临床医学 | 2591篇 |
内科学 | 6832篇 |
皮肤病学 | 521篇 |
神经病学 | 1789篇 |
特种医学 | 944篇 |
外国民族医学 | 5篇 |
外科学 | 5265篇 |
综合类 | 998篇 |
一般理论 | 25篇 |
预防医学 | 2311篇 |
眼科学 | 877篇 |
药学 | 3072篇 |
1篇 | |
中国医学 | 347篇 |
肿瘤学 | 2074篇 |
出版年
2023年 | 320篇 |
2022年 | 927篇 |
2021年 | 1280篇 |
2020年 | 795篇 |
2019年 | 1040篇 |
2018年 | 1221篇 |
2017年 | 805篇 |
2016年 | 820篇 |
2015年 | 968篇 |
2014年 | 1278篇 |
2013年 | 1581篇 |
2012年 | 2311篇 |
2011年 | 2300篇 |
2010年 | 1403篇 |
2009年 | 1015篇 |
2008年 | 1686篇 |
2007年 | 1679篇 |
2006年 | 1519篇 |
2005年 | 1396篇 |
2004年 | 1230篇 |
2003年 | 1066篇 |
2002年 | 940篇 |
2001年 | 737篇 |
2000年 | 655篇 |
1999年 | 553篇 |
1998年 | 217篇 |
1997年 | 156篇 |
1996年 | 152篇 |
1995年 | 164篇 |
1994年 | 110篇 |
1993年 | 126篇 |
1992年 | 274篇 |
1991年 | 268篇 |
1990年 | 239篇 |
1989年 | 241篇 |
1988年 | 184篇 |
1987年 | 215篇 |
1986年 | 168篇 |
1985年 | 176篇 |
1984年 | 149篇 |
1983年 | 110篇 |
1982年 | 80篇 |
1981年 | 89篇 |
1980年 | 67篇 |
1979年 | 138篇 |
1978年 | 88篇 |
1977年 | 87篇 |
1975年 | 84篇 |
1974年 | 70篇 |
1973年 | 72篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
1.
2.
P. A. Hannan J. A. Khan A. Khan S. Safiullah 《Indian journal of pharmaceutical sciences》2016,78(1):2-7
Dosage form is a mean used for the delivery of drug to a living body. In order to get the desired effect the drug should be delivered to its site of action at such rate and concentration to achieve the maximum therapeutic effect and minimum adverse effect. Since oral route is still widely accepted route but having a common drawback of difficulty in swallowing of tablets and capsules. Therefore a lot of research has been done on novel drug delivery systems. This review is about oral dispersible tablets a novel approach in drug delivery systems that are now a day''s more focused in formulation world, and laid a new path that, helped the patients to build their compliance level with the therapy, also reduced the cost and ease the administration especially in case of pediatrics and geriatrics. Quick absorption, rapid onset of action and reduction in drug loss properties are the basic advantages of this dosage form. 相似文献
3.
4.
5.
Ahmed M. Abu El-Asrar Ajmal Ahmad Eef Allegaert Mohammad Mairaj Siddiquei Priscilla W. Gikandi Gert De Hertogh 《Ocular immunology and inflammation》2020,28(4):575-588
ABSTRACT
Purpose
To investigate the expression of IL-11 and its receptor IL-11Rα and to quantify density of CD163+ M2 macrophages in proliferative diabetic retinopathy (PDR). 相似文献6.
7.
Huda Mohammed Alkreathy Mayson H. Alkhatib Safaa Ahmed Al Musaddi Khadijah Saeed A. Balamash Nadia Nour Osman Aftab Ahmad 《Clinical and experimental pharmacology & physiology》2019,46(5):496-505
Doxorubicin (DOX) is the most commonly used anticancer drug; however, it has limited use because prolonged administration may result in severe cardiotoxicity. Simvastatin (SIM), generally prescribed for hypercholesterolaemia, has also shown salubrious results in the monotherapy or combinational drug therapy of different cancers in various models. Nanoparticle drug delivery systems are a novel way of improving therapeutics and also improving the absorption and specificity of drugs towards tumour cells. In this study, we exploited this technology to increase drug specificity and minimize imminent adverse effects. In this study, the antitumour activity of the combination formulas of DOX and SIM, either loaded in water (DOX‐SIM‐Solution) or nanoemulsions (NEs) (DOX‐SIM‐NE), was evaluated in a Swiss albino mouse model of Ehrlich ascites carcinoma. The anticancer effect was assessed by quantifying the change in body weight, mean survival time, and percent increase in lifespan (%ILS), determining haematological and serum biochemical parameters (liver function test, kidney function test and lipid profile parameters) as well as studying the histopathological alterations in liver tissues. We observed a clear increase in %ILS of the DOX‐SIM‐Solution group (265.30) that was double the %ILS of the DOX‐SIM‐NE group (134.70). However, DOX‐SIM‐NE had a non‐toxic effect on the haematological parameters, whereas DOX‐SIM‐Solution increased the levels of haemoglobin and lymphocytes. Furthermore, the encapsulation of SIM and DOX into NEs improved the levels of all serum biochemical parameters compared to the DOX‐SIM‐Solution. A reduction in the side effects of DOX‐SIM‐NE on the liver was also established using light microscopy, which revealed that the morphologies of the hepatocytes of the mice were less affected by administration of the DOX‐SIM‐NE treatment than with the DOX‐SIM‐Solution treatment. The study showed that incorporating SIM into the DOX‐loaded‐NE formulation remarkably improved its efficiency and simultaneously reduced its adverse effects. 相似文献
8.
9.
I Ahmad 《Annals of the Royal College of Surgeons of England》2015,97(7):481-486
Urothelial cell carcinoma (UCC) of the bladder is one of the most common malignancies, causing considerable morbidity and mortality worldwide. It is unique among the epithelial carcinomas as two distinct pathways to tumourigenesis appear to exist: low grade, recurring papillary tumours usually contain oncogenic mutations in FGFR3 or HRAS whereas high grade, muscle invasive tumours with metastatic potential generally have defects in the pathways controlled by the tumour suppressors p53 and retinoblastoma. Over the last two decades, a number of transgenic mouse models of UCC, containing deletions or mutations of key tumour suppressor genes or oncogenes, have helped us understand the mechanisms behind tumour development. In this summary, I present my work investigating the role of the WNT signalling cascade in UCC. 相似文献
10.